Pancreatic Cancer Research

ResearcherHyogo Medical UniversityNo recent work listed

Hiroshi Tsubamoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6135-6313; OpenAlex author ID A5084957996. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Expe… First author DOI 10.21873/anticanres.16118↗
  2. Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting. Co-author PMID 26124377↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Sonoda · 2 shared papers, 2015–2022 · strength 0.23
  2. Shinichi Ikuta · 2 shared papers, 2015–2022 · strength 0.23
  3. Miyuki Sawasaki · 1 shared paper, 2022 · strength 0.17
  4. Naoki Yamanaka · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.